Journal of Reproduction & Infertility

Journal of Reproduction & Infertility

Fertility Preservation in Benign Gynecological Diseases: Current Approaches and Future Perspectives

Authors
1 Lebanese American University, Department of Obstetrics and Gynecology, Beirut, Lebanon
2 Department of Obstetrics and Gynecology, Medical Faculty, Yuzuncu Yil University, Van, Turkey
3 Department of Obstetrics and Gynecology, National Research Center of Mother and Child Health, University Medical Center, Astana, Turkey; Department of Medicine, Nazarbayev University, School of Medicine, Astana, Kazakhstan; Depart
4 Department of Medicine, Nazarbayev University, School of Medicine, Astana, Kazakhstan
5 Obstetrics and Gynaecology Unit, Umberto I Hospital, Enna, Italy
6 Department of Obstetrics and Gynecology, Filippo Del Ponte Hospital, University of Insubria, Varese, Italy
Abstract
Although fertility preservation is a growing topic in the management of oncological diseases, different benign gynecological pathologies are able to compromise the ovarian reserve due to mechanisms related to the pathology itself or secondary to the performed treatments. Endometriosis, benign ovarian tumors, adnexal torsion, familiarity and genetic syndromes are all benign conditions that can compromise the ovarian reserve. Endometriosis and particularly endometriomas provide a direct damage to ovarian reserve, with different mechanisms, and an indirect damage related to surgery. Similarly, benign ovarian tumors can provide a detrimental effect on ovarian reserve for the surgical treatment, especially for bilateral or recurrent tumors, and in case of secondary adnexal torsion with late diagnosis. Different fertility preservation options are available and should be considered particularly in cases with bilateral or recurrent pathology and/or surgery. In general, the identification of patients at risk of early ovarian failure, for benign gynecological disease or based on known genetic causes or familiarity, is of paramount importance in order to apply fertility preservation techniques before the complete depletion of ovarian reserve.
Keywords

  1. Donnez J, Dolmans MM. Fertility preservation in women. N Engl J Med. 2017;378(4):400-1.
  2. Yasmin E, Balachandren N, Davies MC, Jones GL, Lane S, Mathur R, et al. Fertility preservation for medical reasons in girls and women: British fertility society policy and practice guideline. Hum Fertil (Camb). 2018;21(1):3-26.
  3. Practice committee of the american society for reproductive medicine. testing and interpreting measures of ovarian reserve: a committee opinion. Fertil Steril. 2015;103(3):e9-e17.
  4. Wallace WH, Kelsey TW. Human ovarian reserve from conception to the menopause. PLoS One. 2010;5(1):e8772.
  5. Chiofalo B, Palmara V, Laganà AS, Triolo O, Vitale SG, Conway F, et al. Fertility sparing strategies in patients affected by placental site trophoblastic tumor. Curr Treat Options Oncol. 2017;18(10):58.
  6. Vitale SG, Rossetti D, Tropea A, Biondi A, Laganà AS. Fertility sparing surgery for stage IA type I and G2 endometrial cancer in reproductive-aged patients: evidence-based approach and future perspectives. Updates Surg. 2017;69(1):29-34.
  7. de Ziegler D, Borghese B, Chapron C. Endometriosis and infertility: pathophysiology and management. Lancet. 2010;376(9742):730-8.
  8. Maniglio P, Ricciardi E, Meli F, Vitale SG, Noventa M, Vitagliano A, et al. Catamenial pneumothorax caused by thoracic endometriosis. Radiol Case Rep. 2017;13(1):81-5.
  9. Burney RO, Giudice LC. Pathogenesis and pathophysiology of endometriosis. Fertil Steril 2012;98 (3):511-9.
  10. Laganà AS, Vitale SG, Salmeri FM, Triolo O, Ban Frangež H, Vrtačnik-Bokal E, et al. Unus pro omnibus, omnes pro uno: a novel, evidence-based, unifying theory for the pathogenesis of endometriosis. Med Hypotheses. 2017;103:10-20.
  11. Laganà AS, La Rosa VL, Rapisarda AMC, Valenti G, Sapia F, Chiofalo B, et al. Anxiety and depression in patients with endometriosis: impact and management challenges. Int J Womens Health. 2017;9:323-30.
  12. Pope CJ, Sharma V, Sharma S, Mazmanian D. A systematic review of the association between psychiatric disturbances and endometriosis. J Obstet Gynaecol Can. 2015;37(11):1006-15.
  13. Chen LC, Hsu JW, Huang KL, Bai YM, Su TP, Li CT, et al. Risk of developing major depression and anxiety disorders among women with endometriosis: a longitudinal follow-up study. J Affect Disord. 2016;190:282-5.
  14. Vitale SG, La Rosa VL, Rapisarda AMC, Laganà AS. Impact of endometriosis on quality of life and psychological well-being. J Psychosom Obstet Gynaecol. 2017;38(4):317-9.
  15. Duffy JM, Arambage K, Correa FJ, Olive D, Farquhar C, Garry R, et al. Laparoscopic surgery for endometriosis. Cochrane Database Syst Rev. 2014;(4):CD011031.
  16. Raffaelli R, Garzon S, Baggio S, Genna M, Pomini P, Laganà AS, et al. Mesenteric vascular and nerve sparing surgery in laparoscopic segmental intestinal resection for deep infiltrating endometriosis. Eur J Obstet Gynecol Reprod Biol. 2018; 231:214-9.
  17. Laganà AS, Vitale SG, Trovato MA, Palmara VI, Rapisarda AMC, Granese R, et al. Full-thickness excision versus shaving by laparoscopy for intestinal deep infiltrating endometriosis: rationale and potential treatment options. Biomed Res Int. 2016;2016:3617179.
  18. Laganà AS, Garzon S, Franchi M, Casarin J, Gullo G. Translational animal models for endometriosis research: a long and windy road. Ann Transl Med. 2018;6(22):431.
  19. Laganà AS, Salmeri FM, Vitale SG, Triolo O, Götte M. Stem cell trafficking during endometriosis: may epigenetics play a pivotal role? Reprod Sci. 2018;25(7):978-9.
  20. Kitajima M, Defrre S, Dolmans MM, Colette S, Squifflet J, Van Langendonckt A, et al. Endometriomas as a possible cause of reduced ovarian reserve in women with endometriosis. Fertil Steril. 2011;96(3):685-91.
  21. Skinner MK. Regulation of primordial follicle assembly and development. Hum Reprod Update. 2005;11(5):461-71.
  22. Kitajima M, Dolmans MM, Donnez O, Masuzaki H, Soares M, Donnez J. Enhanced follicular recruitment and atresia in cortex derived from ovaries with endometriomas. Fertil Steril. 2014;101 (4):1031-7.
  23. David A, Van Langendonckt A, Gilliaux S, Dolmans MM, Donnez J, Amorim CA. Effect of cryopreservation and transplantation on the expression of kit ligand and anti-Mllerian hormone in human ovarian tissue. Hum Reprod. 2012;27(4):1088-95.
  24. Bina F, Soleymani S, Toliat T, Hajimahmoodi M, Tabarrai M, Abdollahi M, et al. Plant-derived medicines for treatment of endometriosis: a comprehensive review of molecular mechanisms. Pharmacol Res. 2019;139:76-90.
  25. Vetvicka V, Laganà AS, Salmeri FM, Triolo O, Palmara VI, Vitale SG, et al. Regulation of apoptotic pathways during endometriosis: from the molecular basis to the future perspectives. Arch Gynecol Obstet. 2016;294(5):897-904.
  26. Vitale SG, Laganà AS, Nigro A, La Rosa VL, Rossetti P, Rapisarda AM, et al. Peroxisome proliferator-activated receptor modulation during metabolic diseases and cancers: master and minions. PPAR Res. 2016;2016:6517313.
  27. Laganà AS, Vitale SG, Nigro A, Sofo V, Salmeri FM, Rossetti P, et al. Pleiotropic actions of peroxisome proliferator-activated receptors (PPARs) in dysregulated metabolic homeostasis, inflammation and cancer: current evidence and future perspectives. Int J Mol Sci. 2016;17(7). pii: E999.
  28. de Barros IBL, Malvezzi H, Gueuvoghlanian-Silva BY, Piccinato CA, Rizzo LV, Podgaec S. "What do we know about regulatory T cells and endometriosis? a systematic review". J Reprod Immunol. 2017;120:48-55.
  29. Gogacz M, Bogusiewicz M, Putowski L, Adamiak A, Wertel I, Jakowicki JA, et al. [Expression of tumor necrosis factor-alpha (TNF-alpha) on peritoneal fluid mononuclear cells in women with endometriosis]. Ginekol Pol. 2008;79(1):31-5.
  30. Sturlese E, Salmeri FM, Retto G, Pizzo A, De Do-minici R, Ardita FV, et al. Dysregulation of the Fas/FasL system in mononuclear cells recovered from peritoneal fluid of women with endometriosis. J Reprod Immunol. 2011;92(1-2):74-81.
  31. Vitale SG, Capriglione S, Peterlunger I, La Rosa VL, Vitagliano A, Noventa M, et al. The role of oxidative stress and membrane transport systems during endometriosis: a fresh look at a busy corner. Oxid Med Cell Longev. 2018;2018:7924021.
  32. Hamdan M, Dunselman G, Li TC, Cheong Y. The impact of endometrioma on IVF/ICSI outcomes: A systematic review and meta-analysis. Hum Reprod Update. 2015;21(6):809-25.
  33. Somigliana E, Viganò P, Filippi F, Papaleo E, Be-naglia L, Candiani M, et al. Fertility preservation in women with endometriosis: For all, for some, for none? Hum Reprod. 2015;30(6):1280-6.
  34. Dunselman GA, Vermeulen N, Becker C, Calhaz-Jorge C, D’Hooghe T, De Bie B, et al. ESHRE guideline: management of women with endometriosis. Hum Reprod. 2014;29(3):400-12.
  35. Somigliana E, Berlanda N, Benaglia L, Viganò P, Vercellini P, Fedele L. Surgical excision of endometriomas and ovarian reserve: A systematic review on serum antimüllerian hormone level modifications. Fertil Steril. 2012;98(6):1531-8.
  36. Benaglia L, Somigliana E, Vighi V, Ragni G, Vercellini P, Fedele L. Rate of severe ovarian damage following surgery for endometriomas. Hum Reprod. 2010;25(3):678-82.
  37. Somigliana E, Benaglia L, Vigano P, Candiani M, Vercellini P, Fedele L. Surgical measures for endometriosis-related infertility: a plea for research. Placenta. 2011;32 Suppl 3:S238-42.
  38. Coccia ME, Rizzello F, Mariani G, Bulletti C, Pa-lagiano A, Scarselli G. Ovarian surgery for bilateral endometriomas influences age at menopause. Hum Reprod. 2011;26(11):3000-7.
  39. Muzii L, Di Tucci C, Di Feliciantonio M, Marchetti C, Perniola G, Panici PB. The effect of surgery for endometrioma on ovarian reserve evaluated by antral follicle count: a systematic review and meta-analysis. Hum Reprod. 2014;29(10):2190-8.
  40. Ata B, Turkgeldi E, Seyhan A, Urman B. Effect of hemostatic method on ovarian reserve following laparoscopic endometrioma excision; comparison of suture, hemostatic sealant, and bipolar dessication. a systematic review and meta-analysis. J Minim Invasive Gynecol. 2015;22(3):363-72.
  41. Vercellini P, Viganò P, Somigliana E, Fedele L. Endometriosis: pathogenesis and treatment. Nat Rev Endocrinol. 2014;10(5):261-75.
  42. Guo SW. Recurrence of endometriosis and its control. Hum Reprod Update. 2009;15(4):441-61.
  43. Carrillo L, Seidman DS, Cittadini E, Meirow D. The role of fertility preservation in patients with endometriosis. J Assist Reprod Genet. 2016;33(3):317-23.
  44. Rienzi L, Gracia C, Maggiulli R, LaBarbera AR, Kaser DJ, Ubaldi FM, et al. Oocyte, embryo and blastocyst cryopreservation in ART: systematic review and meta-analysis comparing slow-freezing versus vitrification to produce evidence for the development of global guidance. Hum Reprod Update. 2017;23(2):139-55.
  45. Rienzi L, Ubaldi FM. Oocyte versus embryo cryopreservation for fertility preservation in cancer patients: guaranteeing a women’s autonomy. J Assist Reprod Genet. 2015;32(8):1195-6.
  46. Stoop D. Oocyte vitrification for elective fertility preservation: Lessons for patient counseling. Fertil Steril. 2016;105(3):603-4.
  47. Wallace WH, Smith AG, Kelsey TW, Edgar AE, Anderson RA. Fertility preservation for girls and young women with cancer: population-based validation of criteria for ovarian tissue cryopreservation. Lancet Oncol. 2014;15(10):1129-36.
  48. Donnez J, Dolmans MM, Diaz C, Pellicer A. Ovarian cortex transplantation: Time to move on from experimental studies to open clinical application. Fertil Steril. 2015;104(5):1097-8.
  49. Oktay K, Oktem O. Ovarian cryopreservation and transplantation for fertility preservation for medical indications: report of an ongoing experience. Fertil Steril. 2010;93(3):762-8.
  50. Brosens I, Gordts S, Benagiano G. Endometriosis in adolescents is a hidden, progressive and severe disease that deserves attention, not just compassion. Hum Reprod. 2013;28(8):2026-31.
  51. Nelson SM, Telfer EE, Anderson RA. The ageing ovary and uterus: New biological insights. Hum Reprod Update. 2013;19(1):67-83.
  52. Hvidman HW, Petersen KB, Larsen EC, Macklon KT, Pinborg A, Andersen AN. Individual fertility assessment and pro-fertility counselling; Should this be offered to women and men of reproductive age? Hum Reprod. 2015;30(1):9-15.
  53. Garzon S, Laganà AS, Pomini P, Raffaelli R, Ghe-zzi F, Franchi M. Laparoscopic reversible occlusion of uterine arteries and cornuostomy for advanced interstitial pregnancy. Minim Invasive Ther Allied Technol. 2018:1-4.
  54. Garzon S, Raffaelli R, Montin U, Ghezzi F. Primary hepatic pregnancy: report of a case treated with laparoscopic approach and review of the literature. Fertil Steril. 2018;110(5):925-31.
  55. Vercellini P, De Matteis S, Somigliana E, Buggio L, Frattaruolo MP, Fedele L. Long-term adjuvant therapy for the prevention of postoperative endometrioma recurrence: A systematic review and meta-analysis. Acta Obstet Gynecol Scand. 2013;92 (1):8-16.
  56. Frydman R. Introduction: Gynecology surgery and preservation of fertility. Fertil Steril. 2014;101(3):607.
  57. Laganà AS, Sofo V, Salmeri FM, Palmara VI, Triolo O, Terzić MM, et al. Oxidative stress during ovarian torsion in pediatric and adolescent patients: changing the perspective of the disease. Int J Fertil Steril. 2016;9(4):416-23.
  58. Nur Azurah AG, Zainol ZW, Zainuddin AA, Lim PS, Sulaiman AS, Ng BK. Update on the manage-ment of ovarian torsion in children and adolescents. World J Pediatr. 2014;11(1):35-40.
  59. Wang Z, Zhang D, Zhang H, Guo X, Zheng J, Xie H. Characteristics of the patients with adnexal torsion and outcomes of different surgical procedures: a retrospective study. Medicine (Baltimore). 2019;98(5):e14321.
  60. Bertozzi M, Esposito C, Vella C, Briganti V, Zam-pieri N, Codrich D, et al. Pediatric ovarian torsion and its recurrence: a multicenter study. J Pediatr Adolesc Gynecol. 2017;30(3):413-17.
  61. Kaur N, Reid F, Ma K. Ovarian ectopic pregnancy: laparoscopic excision and ovarian conservation. J Minim Invasive Gynecol. 2019;26(6):1006.
  62. Melcer Y, Maymon R, Vaknin Z, Pansky M, Men-dlovic S, Barel O, et al. Primary Ovarian ectopic pregnancy: still a medical challenge. J Reprod Med. 2016;61(1-2):58-62.
  63. Andrade AG, Rocha S, Marques CO, Simões M, Martins I, Biscaia I, et al. Ovarian ectopic pregnancy in adolescence. Clin Case Rep. 2015;3(11):912-5.
  64. Feit H, Leibovitz Z, Kerner R, Keidar R, Sagiv R. Ovarian pregnancy following in vitro fertilization in a woman after bilateral salpingectomy: a case report and review of the literature. J Minim Invasive Gynecol. 2015;22(4):675-7.
  65. Di Paola R, Garzon S, Giuliani S, Laganà AS, Noventa M, Parissone F, et al. Are we choosing the correct FSH starting dose during controlled ovarian stimulation for intrauterine insemination cycles? potential application of a nomogram based on woman’s age and markers of ovarian reserve. Arch Gynecol Obstet. 2018;298(5):1029-35.
  66. Vitale SG, Rossetti P, Corrado F, Rapisarda AM, La Vignera S, Condorelli RA, et al. How to achieve high-quality oocytes? the key role of myo-inositol and melatonin. Int J Endocrinol. 2016;2016:4987436.
  67. Papaleo E, Zaffagnini S, Munaretto M, Vanni VS, Rebonato G, Grisendi V, et al. Clinical application of a nomogram based on age, serum FSH and AMH to select the FSH starting dose in IVF/ICSI cycles: a retrospective two-centres study. Eur J Obstet Gynecol Reprod Biol. 2016;207:94-9.
  68. Artini PG, Di Berardino OM, Papini F, Genazzani AD, Simi G, Ruggiero M, et al. Endocrine and clinical effects of myo-inositol administration in polycystic ovary syndrome. a randomized study. Gynecol Endocrinol. 2013;29(4):375-9.
  69. Laganà AS, Garzon S, Casarin J, Franchi M, Ghe-zzi F. Inositol in polycystic ovary syndrome: restoring fertility through a pathophysiology-based approach. Trends Endocrinol Metab. 2018;29(11):768-80.
  70. Sortino MA, Salomone S, Carruba MO, Drago F. Polycystic ovary syndrome: insights into the therapeutic approach with inositols. Front Pharmacol. 2017;8:341.
  71. Cozzolino M, Vitagliano A, Di Giovanni MV, Laganà AS, Vitale SG, Blaganje M, et al. Ultrasound-guided embryo transfer: summary of the evidence and new perspectives. a systematic review and meta-analysis. Reprod Biomed Online. 2018; 36(5):524-42.
  72. Vitagliano A, Noventa M, Saccone G, Gizzo S, Vitale SG, Laganà AS, et al. Endometrial scratch injury before intrauterine insemination: is it time to re-evaluate its value? evidence from a systematic review and meta-analysis of randomized controlled trials. Fertil Steril. 2018;109(1):84-96.e4.
  73. Nandi A, Sinha N, Ong E, Sonmez H, Poretsky L. Is there a role for vitamin D in human reproduction? Horm Mol Biol Clin Investig. 2016;25(1):15-28.
  74. Laganà AS, Vitale SG, Ban Frangež H, Vrtačnik-Bokal E, D’Anna R. Vitamin D in human reproduction: the more, the better? An evidence-based critical appraisal. Eur Rev Med Pharmacol Sci. 2017;21(18):4243-51.
  75. Reyes-Muñoz E, Sathyapalan T, Rossetti P, Shah M, Long M, Buscema M, et al. Polycystic ovary syndrome: implication for drug metabolism on assisted reproductive techniques-a literature review. Adv Ther. 2018;35(11):1805-15.
  76. Donnez O, Roman H. Choosing the right surgical technique for deep endometriosis: shaving, disc excision, or bowel resection? Fertil Steril. 2017;108(6):931-42.
  77. European society for human reproduction and embryology (ESHRE) guideline group on POI, Webber L, Davies M, Anderson R, Bartlett J, Braat D, et al. ESHRE guideline: management of women with premature ovarian insufficiency. Hum Reprod. 2016;31(5):926-37.
  78. Qin Y, Jiao X, Simpson JL, Chen ZJ. Genetics of primary ovarian insufficiency: New developments and opportunities. Hum Reprod Update. 2015;21(6):787-808.
  79. Grynberg M, Bidet M, Benard J, Poulain M, Sonigo C, Cédrin-Durnerin I, et al. Fertility preservation in Turner syndrome. Fertil Steril. 2016;105(1):13-9.